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SUMMARY
Animal and human data indicate pathological afferent signaling emanating from the carotid body that drives sympathetically mediated elevations in blood pressure in conditions of hypertension. This first-in-man, proof-of-principle study tested the safety and feasibility of unilateral carotid body resection in 15 patients with drug-resistant hypertension. The procedure proved to be safe and feasible. Overall, no change in blood pressure was found. However, 8 patients showed significant reductions in ambulatory blood pressure coinciding with decreases in sympathetic activity. The carotid body may be a novel target for treating an F ound bilaterally at the bifurcation of the common carotid artery, the carotid bodies (CBs) are strategically located to ensure that adequate oxygen is supplied to the brain. With the highest blood flow per tissue weight of any organ (1) , they are exquisitely sensitive to small alterations in blood oxygen, carbon dioxide, pH, and blood flow itself (2, 3) . Despite their small size, the CBs exert powerful reflex effects on the respiratory and cardiovascular system (4) that have been preserved through evolution and are deemed pivotal for survival (5) , perhaps due to their defensive reflex role. This powerful afferent system normally remains quiescent at sea level in resting conditions, but during hypoxia, the CBs are activated, increasing ventilation, increasing sympathetic activity, inducing alkalosis, and contributing to periodic breathing during sleep (6, 7) .
In patients with hypertension, the CBs exhibit both hyper-reflexia and aberrant discharge; in sleep apnea, the activation of the CBs is, in part, responsible for the excessive sympathetic activity and hypertension associated with this condition (8) . Moreover, the hypertension evoked in a rat model of sleep apnea (by chronic intermittent hypoxia), is reliant on afferent activity generated by the CBs (9) , and patients with hypertension may have exaggerated peripheral chemoreflex sensitivity to hypoxia (10, 11) . Additionally, acute reversible inactivation of the CBs, with hyperoxia, caused a transient reduction in blood pressure (BP) and muscle sympathetic nerve activity (MSNA) in patients with hypertension (12) . In rats with hypertension, severing the connection between the CBs and brain lowered both arterial pressure and sympathetic activity chronically (13) . These data point toward the CBs as a therapeutic target to treat sympathetically mediated diseases (14) . The global clinical problem and financial burden of hypertension continues to escalate (15), and 8% to 14% of the 1 billion patients with hypertension worldwide are drug resistant or intolerant (16) . Therefore, new approaches for treating drug-resistant hypertension are justified, as are studies to identify the targets/ mechanisms driving hypertension. We describe the first prospective proof-of-concept, safety and feasibility study of unilateral (u) CB excision from a cohort of patients with drug-resistant hypertension.
We report, secondarily, on the proportion of these patients that showed a response in BP, the hypoxic ventilatory response (HVR), and MSNA.
METHODS
STUDY DESIGN AND PATIENTS. We present pooled results from 2 independent centers in which the primary endpoints were safety and feasibility of uCB excision in patients with drug-resistant hypertension.
Secondary endpoints were to assess the proportion of Following insertion of the microelectrode, resting hemodynamics and MSNA recordings were collected All analyses were conducted blind with respect to the sequence of visits and whether the patient was a BP responder or nonresponder (see the following text).
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All measurements of MSNA burst area and BRS were calculated by importing acquired data into MATLAB 8.0 (2012b, The MathWorks, Natick, Massachusetts), and statistical tests of these measures were Table 1 . 
Abbreviations as in

RESULTS
SAFETY. There were 2 serious adverse events consisting of prolonged hospitalization of patients with BP that was difficult to control. One of the events occurred shortly after the CB removal procedure, and this event was judged by the Clinical Events Committee (CEC) to be "possibly related" to the unilateral removal of the CB. In the other patient, multiple hospitalizations occurred for BP control before and after uCB removal, and the hospitalizations bore no consistent temporal relationship to the CB removal.
These hospitalizations were, therefore, judged by the CEC to be "unrelated" or "unlikely to be related" to the uCB. Table 5 ).
FEASIBILITY. On the basis of its visualization on computed tomography scans (Figure 1) , a CB was resected from either the right (n ¼ 11) or left side Table 2 ). We next determined if there was a proportion of patients that showed a reduction in BP and whether this correlated with any other measured variable. As recently reviewed, CB resection (unilateral and bilateral) has been performed historically for the treatment of dyspnea in patients with asthma and chronic obstructive pulmonary disease (14) . In 1 of these studies, a chronic reduction in BP was noted in patients who had hypertension, which was maintained for 6 months when the study ended; there was no BP change in the normotensive group (25) . 
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Additionally, a retrospective study showed BP reduction in patients with hypertension following uCB tumor resection (26) . Although we saw a worsening of SDB in 1 patient with pre-existing OSA, a systematic analysis of sleep studies in the other patients in this study and in other studies in which the CB was denervated/removed (27) has not demonstrated any consistent change in the severity of OSA. data seen transiently using hyperoxia to inhibit CB afferent activity in humans with hypertension (12) .
We also noted an improvement in MSNA BRS in the responder but not in the nonresponder patients, which could contribute mechanistically to the lowering of BP. This finding is consistent with the known antagonism between peripheral chemoreceptor and baroreflex function (10) . 
The elevated HVR and higher respiratory frequency in the responders versus nonresponders is supportive of aberrant hyper-reflexia and high CB drive, respectively. The elevated HVR is consistent with peripheral chemoreceptor hyper-reflexia in hypertension, as reported in animals (13) and humans with hypertension (8, 11) . It may be possible to use HVR and respiratory frequency (and hyperoxia to depress the CB) (12) to pre-select the patients with hypertension who are most likely to benefit from CB modulation therapy, assuming that their arteries and arterioles are able to vasorelax.
STUDY LIMITATIONS. As a first-in-man, safety and feasibility study, we did not include a control group.
However, in the 1 patient in whom we found no evidence of glomus cells in the resected tissue, we failed to see a fall in BP. Notwithstanding the recruitment difficulties associated with a surgical intervention, we acknowledge that the absence of a control arm and the low number of patients are limitations of the present study. A percutaneous catheter-based approach to ablate the CB selectively may be better tolerated, for example.
Although patients were fully assessed in specialist hypertension clinics before study entry, drug nonadherence cannot be ruled out. Notably, we fully adhered to the established drug adherence procedures at the time the study was initiated (see the Methods sections). There were no statistical differences between screening and baseline OSBP, which may partly overcome concerns regarding a Hawthorne effect and regression to the mean.
Comparing total MSNA from the same patient at different times can be problematic, but we controlled for this by referencing to the largest burst in the neurogram.
REASONS FOR DYSFUNCTIONAL CB. The issue of why the CB develops hypersensitivity is unclear, but may include hypoperfusion as suggested in heart failure (2) . In the hypertensive condition, this may be a result of stenosis caused by atheroma or arteriole hypertrophy; the latter may be induced by elevated sympathetic activity to the CB and/or angiotensin II.
Inflammation is also present in the CB of hypertensive rats (28) and may trigger release of cytokines, chemokines, and reactive oxygen species that could CONCLUSIONS This is the first study that places CB hyper-reflexia in context of a disease state in humans and demonstrates the potential benefit of modifying that activity.
